Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial

Ezio Faglia, Carlo Caravaggi, Giacomo Clerici, Adriana Sganzaroli, Vincenzo Curci, Wanda Vailati, Daniele Simonetti, Francesco Sommalvico, Ezio Faglia, Carlo Caravaggi, Giacomo Clerici, Adriana Sganzaroli, Vincenzo Curci, Wanda Vailati, Daniele Simonetti, Francesco Sommalvico

Abstract

Objective: To evaluate the efficacy of a removable cast walker compared with that of a nonremovable fiberglass off-bearing cast in the treatment of diabetic plantar foot ulcer.

Research design and methods: Forty-five adult diabetic patients with nonischemic, noninfected neuropathic plantar ulcer were randomly assigned for treatment with a nonremovable fiberglass off-bearing cast (total contact cast [TCC] group) or walker cast (Stabil-D group). Treatment duration was 90 days. Percent reduction in ulcer surface area and total healing rates were evaluated after treatment.

Results: A total of 48 patients were screened; however, 2 patients in the TCC group and 1 patient in the Stabil-D group did not complete the study and were considered dropouts. There were no significant differences in demographic and clinic characteristics of the 45 patients completing the study. Ulcer surface decreased from 1.41 to 0.21 cm(2) (P < 0.001) in the TCC group and from 2.18 to 0.45 cm(2) (P < 0.001) in the Stabil-D group, with no significant differences between groups (P = 0.722). Seventeen patients (73.9%) in the TCC group and 16 patients (72.7%) in the Stabil-D group achieved healing (P = 0.794). Average healing time was 35.3 +/- 3.1 and 39.7 +/- 4.2 days in the TCC and Stabil-D group, respectively (P = 0.708).

Conclusions: The Stabil-D cast walker, although removable, was equivalent in efficacy to the TCC in terms of ulcer size reduction and total healing rate. The easier use of Stabil-D may help increase the use of off-loading devices in the management of plantar neuropathic diabetic foot ulcers.

Trial registration: ClinicalTrials.gov NCT01005264.

Figures

Figure 1
Figure 1
“Stabil-D” device and the “Modus” insole. (A high-quality digital representation of this figure is available in the online issue.)
Figure 2
Figure 2
Ulcer size reduction at study completion. *Wilcoxon test. §Mann-Whitney test.
Figure 3
Figure 3
Kaplan-Meier estimate of complete healing rate at study completion.

References

    1. Boulton AJ: The diabetic foot: from art to science: the 18th Camillo Golgi Lecture. Diabetologia 2004; 47: 1343–1353
    1. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998; 21: 1714–1719
    1. Rathur HM, Boulton AJ: Pathogenesis of foot ulcers and the need for offloading. Horm Metab Res 2005; 37(Suppl 1): 61–68
    1. Boulton AJ, Bowker JH, Gadia M, Lemerman R, Caswell K, Skyler JS, Sosenko JM: Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care 1986; 9: 149–152
    1. Brem H, Sheehan P, Boulton AJ: Protocol for treatment of diabetic foot ulcers. Am J Surg 2004; 187: S1–S10
    1. Nabuurs-Franssen MH, Sleegers R, Huijberts MS, Wijnen W, Sanders AP, Walenkamp G, Schaper NC: Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005; 28: 243–247
    1. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB: Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24: 1019–1022
    1. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G: Treatment for diabetic foot ulcers: review. Lancet 2005; 336: 1725–1735
    1. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL: Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments. Diabetes Care 1996; 19: 818–821
    1. Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boulton AJM: Technique for fabrication of an “instant total contact cast” for treatment of neuropathic diabetic foot ulcers. J Am Podistr Assoc 2002; 92: 405–408
    1. Armstrong DG, Lavery LA, Harkless LB: Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1999; 21: 855–859
    1. Dinh MT, Abad CL, Safdar N: Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis 2008; 47: 519–527
    1. Caravaggi C, Faglia E, De Giglio R, Mantero M, Quarantiello A, Sommariva E, Gino M, Pritelli C, Morabito A: Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care 2000; 23: 1746–1751
    1. Birke JA, Pavich MA, Patout CA, Jr, Horswell R: Comparison of forefoot ulcer healing using alternative off-loading methods in patients with diabetes mellitus. Adv Skin Wound Care 2002; 15: 210–215
    1. Mueller MJ, Lott DJ, Hastings MK, Commean PK, Smith KE, Pilgram TK: Efficacy and mechanism of orthotic devices to unload metatarsal heads in people with diabetes and a history of plantar ulcers. Phys Ther 2006; 86: 833–842
    1. Sinacore DR: Total contact casting for diabetic neuropathic ulcers. Phys Ther 1996; 76: 296–301
    1. Guyton GP: An analysis of iatrogenic complications from the total contact cast. Foot Ankle Int 2005; 26: 903–907
    1. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL: Total contact casts: pressure reduction at ulcer sites and the effect on the contralateral foot. Arch Phys Med Rehabil 1997; 78: 1268–1271
    1. Piaggesi A, Macchiarini S, Rizzo L, Palumbo F, Tedeschi A, Nobili LA, Leporati E, Scire V, Teobaldi I, Del Prato S: An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care 2007; 30: 586–590
    1. Caravaggi C, Sganzaroli A, Fabbi M, Cavaiani P, Pogliaghi I, Ferraresi R, Capello F, Morabito A: Nonwindowed nonremovable fiberglass off-loading cast versus removable pneumatic cast (AircastXP Diabetic Walker) in the treatment of neuropathic noninfected plantar ulcers: a randomized prospective trial. Diabetes Care 2007; 30: 2577–2578
    1. Armstrong DG, Lavery LA, Wu S, Boulton AJ: Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005; 28: 551–554
    1. Katz IA, Harlan A, Miranda-Palma B, Prieto-Sanchez L, Armstrong DG, Bowker JH, Mizel MS, Boulton AJ: A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005; 28: 555–559
    1. Chantelau E, Haage P: An audit of cushioned diabetic footwear: relation to patient compliance. Diabet Med 1994; 11: 114–116
    1. Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJ: Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003; 26: 2595–2597
    1. Ha Van G, Siney H, Hartmann-Heurtier A, Jacqueminet S, Greau F, Grimaldi A: Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance. Diabetes Care 2003; 26: 2848–2852

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever